Robert H. Resis is quoted in an IP Law & Business article on the pharmaceutical industry

The article focuses on the state of the generic drug industry and the effects of the Supreme Court’s 2007 KSR decision. Mr. Resis discusses patent appeals in the first 15 months under the KSR rule.

Posted: December 16, 2008

Contact Banner Witcoff Share on LinkedIn View this page as a pdf Share on Twitter Email this page Print this page